Differential inhibition of galanin- and ghrelin-induced food intake by i.c.v. GLP-1(7-36)-amide

Regulatory Peptides

Volumn 147, Issue 1-3, 2008, Pages 29-32

  Schusdziarra, Volker ^a   Zimmermann, Jens Peter ^b   Erdmann, Johannes ^a   Bader, Ulrich ^a   Schick, Rafael R ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c BUNDESWEHRKRANKENHAUS ULM   (Germany)

Author keywords

Feeding regulation; Food intake; Galanin; Ghrelin

Indexed keywords

GALANIN; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; NEUROPEPTIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEEDING BEHAVIOR; FOOD INTAKE; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SATIETY; STIMULATION;

ANIMALS; EATING; GALANIN; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; INJECTIONS, INTRAVENTRICULAR; MALE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

RATTUS;

EID: 40849114402     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2007.12.004     Document Type: Article

References (34)

1. Grossman S.P. Role of the hypothalamus in the regulation of food and water intake. Psychol Rev 82 (1975) 200-224
2. Kalra S., Dube M.G., Pu S., Xu B., Horvath T.L., and Kalra P.S. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20 (1999) 68-100
3. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., and Baskin D.G. Central nervous system control of food intake. Nature 404 (2000) 661-671
4. Schusdziarra V., Zimmermann J.P., and Schick R.R. Importance of orexigenic counter-regulation for multiple targeted feeding inhibition. Obes Res 12 (2004) 627-632
5. Bray G.A., and Tartaglia L.A. Medicinal strategies in the treatment of obesity. Nature 404 (2000) 672-677
6. Jin S.L.C., Han V.K.M., Simmons J.E., Towle A.C., Lander J.M., and Lund P.K. Distribution of glucagon-like peptide 1 (GLP-1), glucagons, and glicentin in the rat brain: an immunohistochemical study. J Comp Neurol 271 (1988) 519-532
7. Larsen P.J., Tang-Christensen M., Holst J.J., and Orskov C. Distribution of glucagon-like peptide-1 and other preglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience 77 (1997) 257-270
8. Göke R., Larsen P.J., Mikkelsen J.D., and Sheikh S.P. Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci 7 (1995) 2294-2300
9. Schick R.R., Zimmermann J.P., vorm W.T., Schusdziarra V., and Classen M. Glucagon-like peptide (GLP)-1 (7-36)amide: a central suppressor of food intake in fasted rats. Gastroenterology 102 (1992) A750
10. Lambert P.D., Wilding J.P.H., Ghatei M.A., and Bloom S.R. A role for GLP-1 (7-36)NH2 in the central control of feeding behavior. Digestion 54 (1993) 360-361
11. Tang-Christensen M., Larsen P.J., Göke R., Fink-Jensen A., Jessop D.S., Moller M., and Sheikh S.P. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol 271 (1996) R848-R856
12. Turton M.D., O'Shea D., Gunn I., Beak S.A., Edwards C.M., Meeran K., Choi S.J., Taylor G.M., Heath M.M., Lambert P.D., Wilding J.P., Smith D.M., Ghatei M.A., Herbert J., and Bloom S.R. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379 (1996) 69-72
13. Schick R.R., Zimmermann J.P., vorm W.T., and Schusdziarra V. Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats. Am J Physiol Regul Integr Comp Physiol 284 (2003) R1427-R1435
14. Nauck M.A., Wollschlager D., Werner J., Holst J.J., Orskov C., Creutzfeld W., and Willms B. Effects of subcutaneous glucagon-like peptide 1 (GLP-1[7-36 amide]) in patients with NIDDM. Diabetologia 88 (1996) 1682-
15. Holst J.J. Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1. Diabetes Metab Res Rev 18 (2002) 430-441
16. Nauck M.A., and Meier J.J. Glucagon-like peptide 1 and its derivatives in the treatment of diabetes. Regul Pept 128 (2005) 135-148
17. DeFronzo R.A., Ratner R.E., Han J., Kim D.D., Fineman M.S., and Baron A.D. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care 28 (2005) 1092-1100
18. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
19. Kyrkouli S.E., Stanley B.G., and Leibowitz S.F. Galanin: stimulation of feeding induced by medial hypothalamic injection of this novel peptide. Eur J Pharmacol 122 (1986) 159-160
20. Kyrkouli S.E., Stanley B.G., Seirafi R.D., and Leibowitz S.F. Stimulation of feeding by galanin: anatomical localization and behavioral specificity of this peptide's effects in the brain. Peptides 11 (1990) 995-1001
21. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., and Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 409 (2001) 194-198
22. Schick R.R., Samsami S., Zimmermann J.P., Eberl T., Endres C., Schusdziarra V., and Classen M. Effect of galanin on food intake in rats: involvement of lateral and ventromedial hypothalamic sites. Am J Physiol 264 (1993) R355-R361
23. Wren A.M., Small C.J., Ward H.L., Murphy K.G., Dakin C.L., Taheri S., Kennedy A.R., Roberts G.H., Morgan D.G., Ghatei M.A., and Bloom S.R. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141 (2000) 4325-4328
24. Bagnasco M., Tulipano G., Melis M.R., Argiolas A., Cocchi D., and Muller E.E. Endogenous ghrelin is an orexigenic peptide acting in the arcuate nucleus in response to fasting. Regul Pept 111 (2003) 161-167
25. Murakami N., Hayashida T., Kuroiwa T., Nakahara K., Ida T., Mondal M.S., Nakazato M., Kojima M., and Kangawa K. Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats. J Endocrinol 174 (2002) 283-288
26. Tschop M., Wawarta R., Riepl R.L., Friedrich S., Bidlingmaier M., Landgraf R., and Folwaczny C. Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 24 (2001) RC19-RC21
27. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E., and Weigle D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50 (2001) 1714-1719
28. Cummings D.E., Frayo R.S., Marmonier C., Aubert R., and Chapelot D. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am J Physiol Endocrinol Metab 287 (2004) E297-E304
29. Erdmann J., Töpsch R., Lippl F., Gussmann P., and Schusdziarra V. Postprandial response of plasma ghrelin levels to various test meals in relation to food intake, plasma insulin and glucose. J Clin Endocrinol Metab 89 (2004) 3048-3054
30. World Health Organisation. Obesity-preventing and managing the global epidemic. Report of a WHO consultation. 894. 2000. Geneva, Switzerland, WHO Technical Report Series.
31. Calle E.E., Thun M.J., Petrelli J.M., Rodriquez C., and Heath C.W. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341 (1999) 1097-1105.
32. Gura T. Obesity drug pipeline not so fat. Science 299 (2003) 849-852
33. James W.P., Astrup A., Finer N., Hilsted J., Kopelman P., Rossner S., Saris W.H., and Van Gaal L.F. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 356 (2000) 2119-2125.
34. Sjostrom L., Rissanen A., Andersen T., Boldrin M., Golay A., Koppeschaar H.P., and Krempf M. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 352 (1998) 167-172.